#drug pricing

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

The new Avita pharmacy specializes in services related to HIV, PrEP, LGBTQ issues and the 340B Drug Pricing Program.

Watch AIDS advocates urge the governor not to abandon efforts to combat HIV, hepatitis and opioid overdoses.

The first generic Truvada is now available in the United States.

Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.

Total payments for the HIV prevention pill exceeded $2 billion in 2018.

A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.

Oncologist wins Senate backing by a vote of 72 to 18.

“Overall, the candidates seemed well informed around HIV/AIDS issues.”

A look at what the law says about buying prescription drugs from Canada.

In the form of direct quotes from the participants

Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.

Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.

Insurance companies can no longer implement harmful co-pay accumulator policies.

Activists want future and retroactive royalties to pay for a national PrEP program.